抗激素治疗药有传统的药剂- 他莫西芬（tamoxifen ）和芳香化酶抑制剂(aromatase inhibitor)，是一天服用1~2次的口服药，不仅有防止复发效果而且副作用小，标准治疗时间是5年。
基于20个网页-相关网页
aromatase inhibitor letrozole 芳香化酶抑制剂来曲唑
aromatase inhibitor antiandrogen 抗雄激素
Aromatase enzyme inhibitor 芳香氨酶抑制剂
Recent advances in the treatment of recombinant human growth hormone,gonadotropin-releasing hormone analogue, aromatase inhibitor in children with ISS were reviewed in detail.
目前对儿童特发性矮小的临床治疗主要集中在重组人生长激素(rhGH)、促性腺激素释放激素类似物(Gn-RHa)和芳香化酶抑制剂(AI)。 文章就其新研究新进展进行综述。
参考来源 - 儿童特发性矮小临床治疗新进展·2,447,543篇论文数据，部分数据来源于NoteExpress
以上来源于: WordNet
N any of a class of drugs that inhibit the action of aromatase: used in the treatment of breast and ovarian cancer 芳香化酶抑制剂
At baseline, 13% of the women were taking an aromatase inhibitor. This rose to 44% by the end of the 24-month study.
基线水平上，13%的妇女正服用芳香化酶抑制剂。两年后，这一比例升高到了44%。
In addition, there was no increased risk of death from other causes in women who were prescribed the aromatase inhibitor.
另外服用芳香酶抑制剂的妇女的其他原因的死亡率没有增加。
In fact, the analysis showed that 132 patients must be treated with an aromatase inhibitor before one cardiovascular problem occurs.
实际上，这个分析显示132名患者在一个心血管疾病出现前，必须用芳香酶抑制剂治疗。
应用推荐